Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Tracy E Madsen, Talia Sobel, Seraphina Negash, Tara Shrout Allen, Marcia L Stefanick, JoAnn E Manson & Matthew Allison. (2023) A Review of Hormone and Non-Hormonal Therapy Options for the Treatment of Menopause. International Journal of Women's Health 15, pages 825-836.
Read now
Read now
Noor A. Nahid & Julie A. Johnson. (2022) CYP2D6 pharmacogenetics and phenoconversion in personalized medicine. Expert Opinion on Drug Metabolism & Toxicology 18:11, pages 769-785.
Read now
Read now
Zhi-Xu He, Xiao-Wu Chen, Zhi-Wei Zhou & Shu-Feng Zhou. (2015) Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine. Drug Metabolism Reviews 47:4, pages 470-519.
Read now
Read now
Articles from other publishers (25)
Harika Topal Önal, Derya Yetkin & Furkan Ayaz. (2023) Paroxetine’s effect on the proinflammatory cytokine stimulation and intracellular signaling pathways in J774.2 cells. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Crossref
Rafia Nimal, Didem Nur Unal, Cem Erkmen, Sevinc Kurbanoglu, Muhammad Siddiq, Gokcen Eren, Afzal Shah & Bengi Uslu. (2023) Elucidating the interaction of antidepressant drug paroxetine with ct-dsDNA: A comparative study by electrochemical, spectroscopic, and molecular docking approaches. Bioelectrochemistry 149, pages 108285.
Crossref
Crossref
Evangelia Eirini Tsermpini, Alessandro Serretti & Vita Dolžan. 2023. Precision Medicine. Precision Medicine
131
186
.
Siu Wa Tang, Wayne H. Tang & Brian E. Leonard. (2021) Treatment-induced mood switching in affective disorders. Acta Neuropsychiatrica 34:2, pages 55-68.
Crossref
Crossref
Magdalena Kowalska, Jacek Nowaczyk, Łukasz Fijałkowski & Alicja Nowaczyk. (2021) Paroxetine—Overview of the Molecular Mechanisms of Action. International Journal of Molecular Sciences 22:4, pages 1662.
Crossref
Crossref
Weibin Zha, Tao Hu, Mary F. Hebert & Joanne Wang. (2019) Effect of Pregnancy on Paroxetine-Induced Adiposity and Glucose Intolerance in Mice. Journal of Pharmacology and Experimental Therapeutics 371:1, pages 113-120.
Crossref
Crossref
Andreas Austgulen Westin, Malin Brekke, Espen Molden, Eirik Skogvoll & Olav Spigset. (2017) Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition. PLOS ONE 12:7, pages e0181082.
Crossref
Crossref
Ruben Vardanyan. 2017. Piperidine-Based Drug Discovery. Piperidine-Based Drug Discovery
127
146
.
Malik Nassan, Wayne T. Nicholson, Michelle A. Elliott, Carolyn R. Rohrer Vitek, John L. Black & Mark A. Frye. (2016) Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine. Mayo Clinic Proceedings 91:7, pages 897-907.
Crossref
Crossref
Ryosuke Arakawa, Amane Tateno, WooChan Kim, Takeshi Sakayori, Kohei Ogawa & Yoshiro Okubo. (2016) Time-course of serotonin transporter occupancy by single dose of three SSRIs in human brain: A positron emission tomography study with [11C]DASB. Psychiatry Research: Neuroimaging 251, pages 1-6.
Crossref
Crossref
Meenu Verma, Anjana Bali, Nirmal Singh & Amteshwar S. Jaggi. (2016) Investigating the role of nisoldipine in foot-shock-induced post-traumatic stress disorder in mice. Fundamental & Clinical Pharmacology 30:2, pages 128-136.
Crossref
Crossref
JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, JS Leeder, RL Graham, DL Chiulli, A LLerena, TC Skaar, SA Scott, JC Stingl, TE Klein, KE Caudle & A Gaedigk. (2015)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for
CYP2D6
and
CYP2C19
Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
. Clinical Pharmacology & Therapeutics 98:2, pages 127-134.
Crossref
Crossref
Alison K. Shea, Tuan-Anh Thi Nguyen, Ursula Brain, Dan Rurak & Tim F. Oberlander. 2014. Psychopharmacology and Pregnancy. Psychopharmacology and Pregnancy
33
46
.
John A. LoweIIIIII. 2013. Drug Discovery. Drug Discovery
245
286
.
Alison K Shea, Tim F Oberlander & Dan Rurak. (2012) Fetal Serotonin Reuptake Inhibitor Antidepressant Exposure: Maternal and Fetal Factors. The Canadian Journal of Psychiatry 57:9, pages 523-529.
Crossref
Crossref
Mojdeh Mozayani. 2012. Handbook of Drug Interactions. Handbook of Drug Interactions
215
227
.
Young Min Lee & Kyoung-Uk Lee. (2011) Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression. Psychiatry and Clinical Neurosciences 65:7, pages 630-637.
Crossref
Crossref
Alessandro Serretti, Sara Gibiino & Antonio Drago. (2011) Specificity profile of paroxetine in major depressive disorder: Meta-regression of double-blind, randomized clinical trials. Journal of Affective Disorders 132:1-2, pages 14-25.
Crossref
Crossref
S. G. Pivina, Yu. O. Fedotova, V. K. Akulova & N. E. Ordyan. (2011) Effects of selective inhibitors of serotonin reuptake on the anxiety behavior and activity of the pituitary-adrenal system in prenatally stressed male rats. Neurochemical Journal 5:1, pages 47-51.
Crossref
Crossref
Charles V Vorhees, LaRonda R Morford, Devon L Graham, Matthew R Skelton & Michael T Williams. (2011) Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug. Behavioral and Brain Functions 7:1, pages 41.
Crossref
Crossref
Keh-Ming Lin, Hsiao-Hui Tsou, I-Ju Tsai, Mei-Chun Hsiao, Chin-Fu Hsiao, Chia-Yih Liu, Winston W Shen, Hwa-Sheng Tang, Chun-Kai Fang, Chi-Shin Wu, Shao-Chun Lu, Hsiang-Wei Kuo, Shu Chih Liu, Hsiu-Wen Chan, Ya-Ting Hsu, Jia-Ni Tian & Yu-Li Liu. (2010)
CYP1A2
genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
. Pharmacogenomics 11:11, pages 1535-1543.
Crossref
Crossref
Mark J. Millan, Anne Dekeyne, Alain Gobert, Clotilde Mannoury la Cour, Mauricette Brocco, Jean-Michel Rivet, Benjamin Di Cara, Françoise Lejeune, Thomas I. Cremers, Gunnar Flik, Trynke R. de Jong, Berend Olivier & Guillaume de Nanteuil. (2010) S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: A comparison to aprepitant (MK869) and paroxetine. European Neuropsychopharmacology 20:9, pages 599-621.
Crossref
Crossref
Chih Chuan Pan, Daih‐Huang Kuo, Pochuen Shieh, Fu‐An Chen, Chun‐Chi Kuo & Chung‐Ren Jan. (2009)
Effect of the antidepressant paroxetine on Ca
2+
movement in PC3 human prostate cancer cells
. Drug Development Research 71:2, pages 120-126.
Crossref
Crossref
Sefi KronenbergAmos Frisch, Beni Rotberg, Miri Carmel, Alan ApterAbraham Weizman. (2008) Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety. Pharmacogenomics 9:11, pages 1725-1736.
Crossref
Crossref
Sheila M. Dowd & Philip G. Janicak. (2008) An Update on Diagnostic and Treatment Issues in the Management of Post-Traumatic Stress Disorder. Psychopharm Review 43:7, pages 51-57.
Crossref
Crossref